Abstract
Soft tissue sarcomas are a heterozygous group of malignancies with various treatment related outcomes that are based on factors such as grade, histology, primary site among others [1–3]. Recent series including a randomized trial from Memorial Sloan Kettering has attempted to define the role of brachytherapy in the treatment of STS. However, as with most reviews this and other reported series are limited in the traditional use or radioactive source such as I-125 or Ir-192 [4–6]. In an effort to help overcome some of the limitations placed on traditional low dose rate brachytherapy, attempts at high dose rate or pulsed high dose rate brachytherapy have been reported [7–8]. During the past thirty years, a remarkable radioactive source (Cf-252) introduced which may offer preferential benefits when compared to the traditionally utilized radiation sources. Although it has been clinically used and described in various sites such as cervix, head and neck, and brain, little has been described in its use for the treatment of STS [9–11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coindre, J.M., Terrier, P., Bui, N.B., Bonichon, F., Collin, F., Le Doussal, V., Manard, A.M., Vilain, M.O., Jacquemier, J., Duplay, H., Sastre, X., Barlier, C., Henry-Amar, M., Mace-Lesech, J., and Contesso, G. (1996) Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the french federation of cancer centers sarcoma group, J. Clinical Oncology 14, 869–877.
Myhre-Jensen, O., Kaae, S., and Hjollund-Madsen, E. (1983) Histopathological grading in soft tissue tumors, APMIS 91, 145–150.
Trojani, M., Contesso, G., and Coindre, J.M. (1984) Soft tissue sarcoma of adults: Study of pathological prognostic variables and definition of a histopathological grading system, Int. J. Cancer 33, 37–42.
Pisters, P.W.T., Harrison, L.B., Leung, D.H.Y., Woddruff, J.M., Casper, E.S., and Brennan, M.F. (1996) Long-term results of a prospective random trial of adjuvant brachytherapy in soft tissue sarcoma, J. Clinical Oncology 14, 859–868.
Janjan, N.A. Yasko, A.W., Reece, G.P., Miller, M.J., Ross, M.I., Romsdahl, M.M., Oswald, M.J., Ochran, T.G., Pollock, R.E. (1994) Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation, Annals of Surgical Oncology 1, 415–422.
O’Connor, M.I., Pritchard, D.J., and Gunderson, L.L. (1993) Integration of limb-sparing surgery, brachytherapy, and external-beam irradiation in the treatment of soft-tissue sarcomas, Clinical Orthopaedics & Related Research 289, 73–80.
Hall, E.J. and Brenner D.J. (1996) Pulsed dose rate brachytherapy: can we take advantage of new technology?, Int. J. Rad. Onc., Bio., Phys. 34, 511–512.
Nag, S., Orton, C.G., and Thomadsen, B. (1996) Remote controlled high dose rate brachytherapy, Crit. Rev. in Oncology-Hematology 22, 127–150.
Maruyama, Y., van Nagell, J.R., Yoneda, J., Donaldson, E.S., Gallion, H.H., Powell, D., and Kiyscio, R.J. (1991) A review of californium-252 neutron brachytherapy for cervical cancer, Cancer 68, 1189–1197.
Patchell, R.A., Maruyama, Y., Tibbs, P.A., Beach, J.L., Kiyscio, R.J., and Young, A.B. (1988) Neutron interstitial brachytherapy for malignant gliomas: A pilot study, J. Neurosurgery 68, 67–72.
Androsov, N.S., Matiakin, G.G., Melenchuk, I.P., and Shumaeva, O.D. (1986) Short-term results of radiotherapy of cancer of the tongue and mouth floor mucosa using Co-60 and Cf-252, Meditsinskaia Radiologiia 31, 3–7.
Zink, S., Antoine, J., and Mahoney, F.J. (1989) Fast neutron therapy clinical trials in the United States, Am. J. Clin. Oncol 12, 277–282.
Schwarz, R., Krull, A., Heyer, D., Baumann, M., Schmidt, R., and Hubener, K.H. (1994) Present results of neutron radiotherapy: The German experience, Acta Oncologica 33, 281-287.
Richardson, M.L., Zink-Brody, G.C., Patten, R.M., Koh, W.J., and Conrad, E.U. (1996) MR characterization of post-irradiation soft tissue edema, Int. Skeletal Soc. 25, 537–543.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fontanesi, J., Zalupski, M., Chuba, P., Wierzbicki, J.G., Rivard, M.J., Ryan, J. (1997). Californium-252 in the Treatment of Soft Tissue Sarcoma. In: Wierzbicki, J.G. (eds) Californium-252 Isotope for 21st Century Radiotherapy. NATO ASI Series, vol 29. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5766-7_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-5766-7_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6433-0
Online ISBN: 978-94-011-5766-7
eBook Packages: Springer Book Archive